No Detail Found!

The spectrum of chronic liver disease in Balochistan

Author(s)
Abdul Baqi Durrani Department of Medicine, Bolan Medical College, Quetta, Pakistan.
Asif Bakhtiar Rana Department of Medicine, Bolan Medical College, Quetta, Pakistan.
Hasan Salman Siddiqi Department of Medicine, Bolan Medical College, Quetta, Pakistan.
Bashir Ullah Marwat Department of Medicine, Bolan Medical College, Quetta, Pakistan.
Abstract
Over the past 3 years (June, 1997 to May, 2000) 160 patients of chronic liver diseases (OLD) were included in a prospective study in Sandeman Provincial Hospital Quetta, to determine the spectrum of chronic liver diseases in Balochistan. Hepatitis C as the major cause of chronic liver diseases was found in 40% cases whereas hepatitis B was positive in 36 % cases. Both the viruses were positive in 7% cases and negative in 17% cases of chronic liver diseases as a whole. Hepatitis C was found in 40 % cases of chronic hepatitis, 44 % cases of cirrhosis of liver, and in 31 % cases of hepatocellular carcinoma, whereas hepatitis B was positive in 38%, 28% and 48% respectively. It reports hepatitis C as a leading cause of chronic hepatitis and cinhosis of liver and hepatitis B as the major contributing factor in hepatocellular carcinoma As chronic liver diseases are very common in Pakistan and is a major community problem, accurate data and effective measures against the spread of these diseases are needed at primary health care level
Publication Details
Page(s) 95-97
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 11, Issue: 2, Year: 2001

Request the full text from PASTIC

Keywords
Chronic liver disease e. Hepatocellular carcinoma Cirrhosis. Chronic hepatitis. Hepatitis C virus. Hepatitis B virus. Etiology
References
Ahmad SM,Malik IA .1997 .TariqWUZ, eta! Hepatitis-Brelated chronicliverdiseasein Rawalpind-i Islamabaadrea. JCPSP, 7(2) : 43-6.
.2000 .Relativferequencoyf hepatitisB virusand hepatiticC virusinfectionsin patientsof cirrhosiisn NWFP. JCPSP, 10(6) : 217-9.
Shamsuddin S. .1998 .PortalSystemicencephalopathiyn chronicliverdisease:experienceof PeoplesMedical CollegeN, awabshahJ. CPSP, 8(2) : 53-55.
.1988 .Progresisn thecontroolf viral hepatitism:emorandumfroma WHO meeting. BullWHO, 66 : 443-55.
Seidal S,Stargel W .1989 .. Lancet, 2 : 234.
Ml Khadim .1993 .Prevalencoef hepatitis-Bantigenin var­i Virologicaplrofilesin patientwith multiplehepatitis ous populationgroupof NWFP. Clinicaalnd, 105 : 1529-33.
Malik IA,Khan SA,Tariq WUZ .1998 .HepatitisC virus in perspectivew:heredo we stand. JCPSP, 6(40) : 5-186.
Ryan KE,MclennanS KE,Barber JA,Alter MJ,Shafi T,Iqbal J,Ahmed S.,Prevalencoef S. . .MargolisHS, KrawezynskiK, eta! The natural anti-HCVblooddonors. nnIntern W1994, 2 : 1899-1905.
Tang ZY,Yang BH,Secondarpyreventioonf BH . .. GastrotHepatol0, : 683-90.
Maynord JE,Kane MA,Holder SC .1989 .Globalcontroolf hepatitisB through vaccine in the expanded programmeon Immunization. S 574, 11(suppl) : .
Sung JL .1990 .8 Suppl:S 96-. The Asianregionalstudygroup. Vaccine, : .
Fay OH. .1990 .8 (suppl):S 100-. , : discussioSn134-9.
Shaikh MH,Shams K. Prevalencoef .1995 .HBV markerisn healthcarpersonnevlsmatchedcontrolJC. PSP, 5 : 19-21.
.1989 .. Antibodies tohepatitisC virus.Lancet, 2 : 324-5.
Bottelli R,Tibbals J,HockhouseDr J .1998 .Ultrasound screeningfor hepatocellulcaarrcinom ain cirrhosis: the evidencefor an establishedclinicalpractice. dinRadiol, 53 : 713-6.
0

Citations

0

Downloads

87

Views